(Q55471053)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

Adaptive radiation therapy

7 January 2020

main subject

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jeffrey Allen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Roger J Packer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Mark Krailo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Katherine Warren

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Regina Jakacki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Judith G Villablanca

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Akiko Chiba

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Gregory Reaman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

1 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1968-1974

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16177987%20AND%20SRC:MED&resulttype=core&format=json

Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Carboplatin and recurrent childhood brain tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Osmotic opening of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Bradykinin receptor types and B2 subtypes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Bradykinin-Degrading Enzymes: Structure, Function, Distribution, and Potential Roles in Cardiovascular Pharmacology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

The effect of hyperosmotic blood-brain barrier disruption on blood-to-tissue transport in ENU-induced gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Dissociation of blood-brain barrier permeability and the hypotensive effects of the bradykinin B2 agonist, RMP-7

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021

A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21403

7 January 2021